335 related articles for article (PubMed ID: 9864227)
1. Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model.
Sawai N; Kita M; Kodama T; Tanahashi T; Yamaoka Y; Tagawa Y; Iwakura Y; Imanishi J
Infect Immun; 1999 Jan; 67(1):279-85. PubMed ID: 9864227
[TBL] [Abstract][Full Text] [Related]
2. Role of tumor necrosis factor-alpha and interferon-gamma in Helicobacter pylori infection.
Yamamoto T; Kita M; Ohno T; Iwakura Y; Sekikawa K; Imanishi J
Microbiol Immunol; 2004; 48(9):647-54. PubMed ID: 15383700
[TBL] [Abstract][Full Text] [Related]
3. IgA antibodies impair resistance against Helicobacter pylori infection: studies on immune evasion in IL-10-deficient mice.
Akhiani AA; Stensson A; Schön K; Lycke NY
J Immunol; 2005 Jun; 174(12):8144-53. PubMed ID: 15944323
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice.
Smythies LE; Waites KB; Lindsey JR; Harris PR; Ghiara P; Smith PD
J Immunol; 2000 Jul; 165(2):1022-9. PubMed ID: 10878379
[TBL] [Abstract][Full Text] [Related]
5. Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells.
Akhiani AA; Pappo J; Kabok Z; Schön K; Gao W; Franzén LE; Lycke N
J Immunol; 2002 Dec; 169(12):6977-84. PubMed ID: 12471132
[TBL] [Abstract][Full Text] [Related]
6. Local secretory immunoglobulin A and postimmunization gastritis correlate with protection against Helicobacter pylori infection after oral vaccination of mice.
Goto T; Nishizono A; Fujioka T; Ikewaki J; Mifune K; Nasu M
Infect Immun; 1999 May; 67(5):2531-9. PubMed ID: 10225917
[TBL] [Abstract][Full Text] [Related]
7. IL-17 is involved in Helicobacter pylori-induced gastric inflammatory responses in a mouse model.
Shiomi S; Toriie A; Imamura S; Konishi H; Mitsufuji S; Iwakura Y; Yamaoka Y; Ota H; Yamamoto T; Imanishi J; Kita M
Helicobacter; 2008 Dec; 13(6):518-24. PubMed ID: 19166417
[TBL] [Abstract][Full Text] [Related]
8. Effects of oral vaccination and immunomodulation by cholera toxin on experimental Helicobacter pylori infection, reinfection, and gastritis.
Raghavan S; Svennerholm AM; Holmgren J
Infect Immun; 2002 Aug; 70(8):4621-7. PubMed ID: 12117975
[TBL] [Abstract][Full Text] [Related]
9. Vaccine-induced reduction of Helicobacter pylori colonization in mice is interleukin-12 dependent but gamma interferon and inducible nitric oxide synthase independent.
Garhart CA; Heinzel FP; Czinn SJ; Nedrud JG
Infect Immun; 2003 Feb; 71(2):910-21. PubMed ID: 12540573
[TBL] [Abstract][Full Text] [Related]
10. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection.
Shi T; Liu WZ; Gao F; Shi GY; Xiao SD
Helicobacter; 2005 Feb; 10(1):71-9. PubMed ID: 15691317
[TBL] [Abstract][Full Text] [Related]
11. Inflammation, immunity, and vaccines for Helicobacter infection.
Permin H; Andersen LP
Helicobacter; 2005; 10 Suppl 1():21-5. PubMed ID: 16178967
[TBL] [Abstract][Full Text] [Related]
12. Development of a mouse model of Helicobacter pylori infection that mimics human disease.
Marchetti M; Aricò B; Burroni D; Figura N; Rappuoli R; Ghiara P
Science; 1995 Mar; 267(5204):1655-8. PubMed ID: 7886456
[TBL] [Abstract][Full Text] [Related]
13. A coordinated cytotoxic effect of IFN-gamma and cross-reactive antibodies in the pathogenesis of Helicobacter pylori gastritis.
Itoh T; Yoshida M; Chiba T; Kita T; Wakatsuki Y
Helicobacter; 2003 Aug; 8(4):268-78. PubMed ID: 12950599
[TBL] [Abstract][Full Text] [Related]
14. Defining the Roles of IFN-γ and IL-17A in Inflammation and Protection against Helicobacter pylori Infection.
Sjökvist Ottsjö L; Flach CF; Nilsson S; Malefyt Rde W; Walduck AK; Raghavan S
PLoS One; 2015; 10(7):e0131444. PubMed ID: 26168305
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori Depletes Cholesterol in Gastric Glands to Prevent Interferon Gamma Signaling and Escape the Inflammatory Response.
Morey P; Pfannkuch L; Pang E; Boccellato F; Sigal M; Imai-Matsushima A; Dyer V; Koch M; Mollenkopf HJ; Schlaermann P; Meyer TF
Gastroenterology; 2018 Apr; 154(5):1391-1404.e9. PubMed ID: 29273450
[TBL] [Abstract][Full Text] [Related]
16. Oral immunization with recombinant Mycobacterium smegmatis expressing the outer membrane protein 26-kilodalton antigen confers prophylactic protection against Helicobacter pylori infection.
Lü L; Zeng HQ; Wang PL; Shen W; Xiang TX; Mei ZC
Clin Vaccine Immunol; 2011 Nov; 18(11):1957-61. PubMed ID: 21900527
[TBL] [Abstract][Full Text] [Related]
17. The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization.
Akhiani AA; Stensson A; Schön K; Lycke N
Scand J Immunol; 2006 Feb; 63(2):97-105. PubMed ID: 16476008
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori-specific antibodies impair the development of gastritis, facilitate bacterial colonization, and counteract resistance against infection.
Akhiani AA; Schön K; Franzén LE; Pappo J; Lycke N
J Immunol; 2004 Apr; 172(8):5024-33. PubMed ID: 15067084
[TBL] [Abstract][Full Text] [Related]
19. Changes in gastric microbiota induced by Helicobacter pylori infection and preventive effects of Lactobacillus plantarum ZDY 2013 against such infection.
Pan M; Wan C; Xie Q; Huang R; Tao X; Shah NP; Wei H
J Dairy Sci; 2016 Feb; 99(2):970-981. PubMed ID: 26709179
[TBL] [Abstract][Full Text] [Related]
20. Atrophic gastric changes in both Helicobacter felis and Helicobacter pylori infected mice are host dependent and separate from antral gastritis.
Sakagami T; Dixon M; O'Rourke J; Howlett R; Alderuccio F; Vella J; Shimoyama T; Lee A
Gut; 1996 Nov; 39(5):639-48. PubMed ID: 9026476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
